Evidence map›Paper›PMID 27624454›Full record

ReviewChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2016

Desmoplastic astrocytoma: new insights into its clinical profile, diagnosis, and treatment.

L M Rojas-Medina, R Carrasco-Moro, M Rivero-Garvía, L Esteban-Fernández, E Rivas-Infante, J Márquez-Rivas

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Intracranial Tumors in the First Year of Life.Advances and technical standards in neurosurgery · 2023
    Article
  4. Article
  5. Uncommon low-grade brain tumors.Neuro-oncology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

L M Rojas-MedinaDepartment of Neurosurgery, Ramón y Cajal University Hospital, Ctra. de Colmenar Viejo Km 9,100, 7th floor, Madrid, 28034, Spain. luismarianorojas@gmail.com.
R Carrasco-MoroDepartment of Neurosurgery, Ramón y Cajal University Hospital, Ctra. de Colmenar Viejo Km 9,100, 7th floor, Madrid, 28034, Spain.
M Rivero-GarvíaDepartment of Pediatric Neurosurgery, Virgen del Rocío University Hospital, Sevilla, Spain.
L Esteban-FernándezDepartment of Neurology, Nuestra Señora del Rosario Hospital, Madrid, Spain.
E Rivas-InfanteDepartment of Pathology, Virgen del Rocío University Hospital, Sevilla, Spain.
J Márquez-RivasDepartment of Pediatric Neurosurgery, Virgen del Rocío University Hospital, Sevilla, Spain.
Hospital Universitario Virgen del Rocío · ESInstituto Cajal · ESHospital Nuestra Señora de Alarcos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDesmoplastic astrocytoma (DA) is a rare intracranial tumor which usually affects pediatric patients. The aim of this study is to describe the clinical features and management of DA based on a joint analysis of the cases reported in the scientific literature. MATERIAL AND

methodsA thorough review was carried out, gathering those pathologically proven DAs reported since the first description of this entity. Two new own cases were included in order to illustrate this review. Epidemiological, clinical, radiological, therapeutic, and follow-up data were analyzed with the software SPSS version 20.

resultsA total of 52 DAs were recorded. Most cases occurred in the first 2 years of life, although older patients were also reported. Patients mainly presented symptoms and signs of elevated intracranial pressure. According to their radiological features, we were able to classify DAs in four main groups, with distinct differential diagnosis and prognosis. After treatment, 14.2 % of patients presented persistent neurological impairment and the mortality rate was close to 10 %.

conclusionDAs can be diagnosed at any age from birth to adolescence. These neoplasms can show up a wider range of radiological morphologies than previously thought. Surgery represents the treatment of choice for DAs, although chemotherapy can also be useful in the setting of recurrence or progression of the disease. Those DAs lacking classic radiological features, especially type 4 tumors, were linked with a poorer clinical outcome.

Indexed as

AdolescentAntineoplastic AgentsAstrocytomaBrain NeoplasmsCarcinoma, Small CellChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfant, NewbornIntracranial PressureMagnetic Resonance ImagingMaleNeurosurgical ProceduresAntineoplastic AgentsDesmoplastic astrocytomaInfancyInfantile neuroepithelial tumors

Identifiers

PMID27624454
OpenAlexW2518221513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.